Hemostasis Products Market Outlook:
Hemostasis Products Market size was valued at USD 2.19 billion in 2025 and is likely to cross USD 3.78 billion by 2035, expanding at more than 5.6% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of hemostasis products is assessed at USD 2.3 billion.
The growth of the market can be attributed primarily to the rising prevalence of cardiovascular diseases worldwide, owing to adoption of unhealthy lifestyle, consumption of unhealthy food products and rising illnesses among the population. According to the World Health Organization, in 2019, 17.9 million people died from cardiovascular diseases, representing 32% of all deaths worldwide. Heart attacks and strokes accounted for 85% of these deaths.
To promote wound healing, hemostasis prevents or slows down blood flow or clotting following injury. Hemostatic products that are based on tissue are widely used to pack wounds after a severe injury. Furthermore, the rising medical tourism, higher investments by government in development of hemostasis products, huge base of geriatric population coupled with large number of blood disorders patient population are expected to drive global hemostasis products market growth during the forecast period.
